BioSpace News Archive

Pictured: BMS sign on a building in San Diego, California/iStock, JHVEPhoto

Cancer

BMS’ Phase III Opdualag Melanoma Fail Could Limit Market Opportunity: Analysts

The failure in adjuvant melanoma could cause BMS and Opdualag to miss out on a market opportunity that is nearly twice as large as its current approved indication, according to analysts.

February 14, 2025

·

2 min read

·

Tristan Manalac

Composite photo collage of massive hairy hands hold wad money count dollars earnings income wealth isolated on painted background.

Immunology and Inflammation

I&I Startup Bambusa Nabs $90M for Bispecific Antibodies

The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related indications.

February 14, 2025

·

1 min read

·

Dan Samorodnitsky

Two hands locked in a handshake cut by a pair of scissors, symbolizing a severed relationship or partnership. Black and white collage illustration on paper textured background

Collaboration

Amgen, Ideaya Call It Quits on Cancer Combo

Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in MTAP-null advanced non-small cell lung cancer.

February 14, 2025

·

2 min read

·

Tristan Manalac

Pictured: Facade of Moderna's building in Massachusetts

Earnings

Moderna Reports Higher-Than-Expected Losses While Anticipating Layoffs

In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal anticipated cuts to the company’s digital team.

February 14, 2025

·

3 min read

·

Tristan Manalac

Speech balloon conversation in puzzle shape vector illustration card. Human hands exchange information in retro 80s collage vector illustration. Concept of success in communication, support, cooperation; new projects, professional growth.

Immunology and inflammation

Pliant Brings in Outside Experts to Review IPF Study Pause

The experts will assess unblinded data from BEACON-IPF to figure out why a data safety monitoring board recommended suspension of the idiopathic pulmonary fibrosis trial.

February 14, 2025

·

2 min read

·

Tristan Manalac

Press Releases

Oncotelic CEO Vuong Trieu to Present Groundbreaking Research on Transforming Growth Factor Beta 2 (TGFB2) at SWCR 2025 Conference

February 14, 2025

·

6 min read

Press Releases

Bio-Path Holdings Provides Key Clinical Updates